CorMedix, Inc. (CRMD)
7.935
+0.12
(+1.47%)
USD |
NASDAQ |
May 20, 16:00
7.85
-0.08
(-1.07%)
After-Hours: 07:51
CorMedix Profit Margin (Quarterly) : 30.29% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 18.75% |
| Eli Lilly & Co. | 37.36% |
| Theravance Biopharma, Inc. | -27.87% |
| Hyperion DeFi, Inc. | -- |
| Corcept Therapeutics, Inc. | -18.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 58.32% |
| Return on Assets | 31.80% |
| Return on Invested Capital | 48.89% |
| Gross Profit Margin (Quarterly) | 82.50% |
| Operating Margin (Quarterly) | 49.96% |
| Return on Net Operating Assets | 45.69% |